Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Horizon: building the next wave of biotech growth at the Biotech Campus Delft
A new development is on the horizon for the Biotech Campus Delft. With the working title Horizon, ASR Dutch Science Park Fund, together with dsm-firmenich and Planet B.io, is taking the next step in further strengthening the campus as a leading European hub where biotech innovation, collaboration, and scale come together.
High-level Government visit highlights Delft's strategic role in future industrial biotech growth
On 11 March, Erwin Nijsse, Director-General at the Ministry of Economic Affairs and Climate, visited Planet B.io. The visit aligns well with the Netherlands’ evolving political and economic direction and therefore he was joined by a broad delegation of colleagues from several ministries.
Turning waste into value: Bootcamp winners BioFire and Akin to join Planet B.io
Meet BioFire and Akin: two emerging biotech startups that are turning complex waste challenges into scalable, high-value solutions. Following their success in the Bootcamp, both companies are now taking the next step by joining the ecosystem of Planet B.io on the Biotech Campus Delft.